Your browser doesn't support javascript.
loading
Decitabine salvage for TP53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy.
Ferraro, Francesca; Gruszczynska, Agata; Ruzinova, Marianna B; Miller, Christopher A; Percival, Mary Elizabeth; Uy, Geoffrey L; Pusic, Iskra; Jacoby, Meagan A; Christopher, Mathew J; Kim, Miriam Y; Westervelt, Peter; Cashen, Amanda F; Schroeder, Mark A; DiPersio, John F; Abboud, Camille N; Wartman, Lukas D; Gao, Feng; Link, Daniel C; Ley, Timothy J; Welch, John S.
Affiliation
  • Ferraro F; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Gruszczynska A; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Ruzinova MB; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Miller CA; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Percival ME; Department of Internal Medicine, Division of Hematology, University of Washington School of Medicine, Seattle, Washington 98195; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.
  • Uy GL; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Pusic I; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Jacoby MA; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Christopher MJ; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Kim MY; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Westervelt P; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Cashen AF; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Schroeder MA; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • DiPersio JF; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Abboud CN; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Wartman LD; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Gao F; Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Link DC; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Ley TJ; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Welch JS; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110.
Haematologica ; 107(7): 1709-1713, 2022 07 01.
Article in En | MEDLINE | ID: mdl-35236053
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Agents Limits: Humans Language: En Journal: Haematologica Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Agents Limits: Humans Language: En Journal: Haematologica Year: 2022 Document type: Article